| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 9, Issue 11 949-959, Copyright © 1998 by American Association of Cancer Research
ARTICLES |
KM Catron, JR Brickwood, C Shang, Y Li, MF Shannon and TP Parks
Department of Inflammatory Diseases, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877-0368, USA. kcatron@bi-pharm.com
Intercellular adhesion molecule-1 (ICAM-1) is up-regulated on numerous cell types in response to inflammatory cytokines. Tumor necrosis factor-alpha (TNF-alpha) activates the ICAM-1 promoter through a variant nuclear factor-kappaB (NF-kappaB) site at -187/-178 bp upstream of the transcription start site. In this investigation, we provide biochemical and functional evidence that an adjacent CCAAT/enhancer binding protein (C/EBP) site and this variant NF-kappaB site define a composite element for activation of the ICAM-1 promoter in certain cell lines. We detected an endogenous TNF-alpha-inducible DNA-protein complex in nuclear extracts from A549, HeLa, and EVC304 cells that contained both RelA and C/EBPbeta but not other family members. Complex formation required intact C/EBP and NF-kappaB sites and was absolutely dependent on translocation of RelA into the nucleus. Complex formation and cooperative binding were also demonstrated using recombinant proteins, and as above, both binding sites were necessary. Interestingly, the RelA/C/EBPbeta complex was not detected in either Jurkat or Raji cells, indicating cell type specificity. Functional studies with various reporter gene constructs revealed that both binding sites were required for maximal activation of the ICAM-1 promoter in response to TNF-alpha and for synergistic activation by RelA and C/EBPbeta. This is the first detailed analysis of how RelA and C/EBPbeta function to regulate ICAM-1 expression, and this study has important implications for how this gene is activated in specific cell types.
This article has been cited by other articles:
![]() |
K. Morimoto, J. Gosselink, A. Kartono, J. C. Hogg, S. Hayashi, and E. Ogawa Adenovirus E1A regulates lung epithelial ICAM-1 expression by interacting with transcriptional regulators at its promoter Am J Physiol Lung Cell Mol Physiol, March 1, 2009; 296(3): L361 - L371. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Manzel, C. L. Chin, M. A. Behlke, and D. C. Look Regulation of Bacteria-Induced Intercellular Adhesion Molecule-1 by CCAAT/Enhancer Binding Proteins Am. J. Respir. Cell Mol. Biol., February 1, 2009; 40(2): 200 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Chumakov, A. Silla, E. A. Williamson, and H. P. Koeffler Modulation of DNA binding properties of CCAAT/enhancer binding protein epsilon by heterodimer formation and interactions with NFkappaB pathway Blood, May 15, 2007; 109(10): 4209 - 4219. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Paz-Priel, D. H. Cai, D. Wang, J. Kowalski, A. Blackford, H. Liu, C. A. Heckman, A. F. Gombart, H. P. Koeffler, L. M. Boxer, et al. CCAAT/Enhancer Binding Protein {alpha} (C/EBP{alpha}) and C/EBP{alpha} Myeloid Oncoproteins Induce Bcl-2 via Interaction of Their Basic Regions with Nuclear Factor-{kappa}B p50 Mol. Cancer Res., October 1, 2005; 3(10): 585 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shimba, T. Wada, S. Hara, and M. Tezuka EPAS1 Promotes Adipose Differentiation in 3T3-L1 Cells J. Biol. Chem., September 24, 2004; 279(39): 40946 - 40953. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Papin, C. Cazeneuve, P. Duquesnoy, I. Jeru, D. Sahali, and S. Amselem The Tumor Necrosis Factor {alpha}-dependent Activation of the Human Mediterranean Fever (MEFV) Promoter Is Mediated by a Synergistic Interaction between C/EBP{beta} and NF{kappa}B p65 J. Biol. Chem., December 5, 2003; 278(49): 48839 - 48847. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Edelstein, L. Lagos, M. Simmons, H. Tirumalai, and C. Gelinas NF-{kappa}B-Dependent Assembly of an Enhanceosome-Like Complex on the Promoter Region of Apoptosis Inhibitor Bfl-1/A1 Mol. Cell. Biol., April 15, 2003; 23(8): 2749 - 2761. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sugita, T. Kohno, K. Yamamoto, Y. Imaizumi, H. Nakajima, T. Ishimaru, and T. Matsuyama Induction of Macrophage-Inflammatory Protein-3{alpha} Gene Expression by TNF-Dependent NF-{kappa}B Activation J. Immunol., June 1, 2002; 168(11): 5621 - 5628. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Darville and D. L. Eizirik Cytokine Induction of Fas Gene Expression in Insulin-Producing Cells Requires the Transcription Factors NF-{kappa}B and C/EBP Diabetes, August 1, 2001; 50(8): 1741 - 1748. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Elberg, J. M. Gimble, and S. Y. Tsai Modulation of the Murine Peroxisome Proliferator-activated Receptor gamma 2 Promoter Activity by CCAAT/Enhancer-binding Proteins J. Biol. Chem., September 1, 2000; 275(36): 27815 - 27822. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |